Claims for harm from Allergan implants in Washington

Washington has a 3-year personal injury statute under RCW § 4.16.080 with the discovery rule. Washington plaintiffs file in MDL 2921 in the District of New Jersey or may pursue claims in Washington state court (King County Superior Court for Seattle-area plaintiffs). Seattle, Bellevue, and the greater Puget Sound region have active cosmetic surgery markets that placed Allergan BIOCELL products during the 2005–2019 period. The Pacific region — California, Oregon, and Washington — accounts for approximately 37% of U.S. breast augmentation volume, reflecting a large BIOCELL implant exposure population in Washington State. BIA-ALCL diagnoses in Washington from 2023 onward are within the 3-year limitations period.